IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Cipla has a robust governance model focused on sustainability
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Subscribe To Our Newsletter & Stay Updated